# InvestorNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) Expands Non-Invasive Drug Testing Portfolio With SmarTest Patch

Intelligent Bio Solutions (NASDAQ: INBS), a medical technology company specializing in rapid, non-invasive testing, has added the SmarTest(R) Patch to its product lineup. Developed by SMARTOX(R), the wearable patch enables continuous drug detection via sweat over 7 to 10 days, complementing INBS’s Intelligent Fingerprinting Drug Testing Solution. The discreet, water-resistant, tamper-evident device detects substances such as cocaine, opiates, methamphetamines, marijuana and fentanyl. With differing detection windows, the two products allow INBS to meet a broader range of customer needs, especially in justice and rehabilitation settings, and strengthen its position as a leader in non-invasive drug testing.

 To view the full article, visit https://ibn.fm/4mgLj

 About Intelligent Bio Solutions Inc.

 Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company delivering intelligent, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for the recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries. The Company’s current customer segments outside the US include construction, manufacturing and engineering, transport and logistics firms, drug treatment organizations, and coroners.

 NOTE TO INVESTORS: The latest news and updates relating to INBS are available in the company’s newsroom at https://ibn.fm/INBS

 About InvestorWire

 InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

 For more information, please visit https://www.InvestorWire.com

 Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

 InvestorWireAustin, Texaswww.InvestorWire.com512.354.7000 OfficeEditor@InvestorWire.com

 InvestorWire is powered by IBN 

---

[Original/Source Press Release](https://rss.investorbrandnetwork.com/iw/investornewsbreaks-intelligent-bio-solutions-inc-nasdaq-inbs-expands-non-invasive-drug-testing-portfolio-with-smartest-patch/)
                    

[Newsramp.com TLDR](https://newsramp.com/curated-news/intelligent-bio-solutions-enhances-drug-testing-with-smartest-r-patch/95fad69c01711528d0cd1ee5a089f44f) 

 



[Reddit Post](https://www.reddit.com/r/Business_NewsRamp/comments/1m0jg6f/intelligent_bio_solutions_enhances_drug_testing/) 



![Blockchain Registration](https://cdn.newsramp.app/ibn/qrcode/257/15/lambSO4I.webp)